SGLT-2 inhibitors as First-Line Therapy in Type 2 Diabetes? - Medscape

Real-world study finds heart failure hospitalization reduction compared to metformin but not MI, stroke, or overall mortality, and greater genital infection risk.

Use of sodiumglucose cotransporter-2 (SGLT-2) inhibitors rather than metformin as first-line treatment for type 2 diabetes appears to cut the risk for heart failure hospitalization but not myocardial… [+7659 chars]

full article...